185 related articles for article (PubMed ID: 25211222)
1. The TIR-domain containing adaptor TRAM is required for TLR7 mediated RANTES production.
Shevlin E; Miggin SM
PLoS One; 2014; 9(9):e107141. PubMed ID: 25211222
[TBL] [Abstract][Full Text] [Related]
2. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
[TBL] [Abstract][Full Text] [Related]
3. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
[TBL] [Abstract][Full Text] [Related]
4. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
[TBL] [Abstract][Full Text] [Related]
5. Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-β and RANTES production.
Siednienko J; Gajanayake T; Fitzgerald KA; Moynagh P; Miggin SM
J Immunol; 2011 Feb; 186(4):2514-22. PubMed ID: 21248248
[TBL] [Abstract][Full Text] [Related]
6. SLAMF1 is required for TLR4-mediated TRAM-TRIF-dependent signaling in human macrophages.
Yurchenko M; Skjesol A; Ryan L; Richard GM; Kandasamy RK; Wang N; Terhorst C; Husebye H; Espevik T
J Cell Biol; 2018 Apr; 217(4):1411-1429. PubMed ID: 29440514
[TBL] [Abstract][Full Text] [Related]
7. TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway.
Palsson-McDermott EM; Doyle SL; McGettrick AF; Hardy M; Husebye H; Banahan K; Gong M; Golenbock D; Espevik T; O'Neill LA
Nat Immunol; 2009 Jun; 10(6):579-86. PubMed ID: 19412184
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain.
Piao W; Ru LW; Piepenbrink KH; Sundberg EJ; Vogel SN; Toshchakov VY
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19036-41. PubMed ID: 24194546
[TBL] [Abstract][Full Text] [Related]
9. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
11. The TLR signaling adaptor TRAM interacts with TRAF6 to mediate activation of the inflammatory response by TLR4.
Verstak B; Stack J; Ve T; Mangan M; Hjerrild K; Jeon J; Stahl R; Latz E; Gay N; Kobe B; Bowie AG; Mansell A
J Leukoc Biol; 2014 Sep; 96(3):427-36. PubMed ID: 24812060
[TBL] [Abstract][Full Text] [Related]
12. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
[TBL] [Abstract][Full Text] [Related]
13. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory response to Porphyromonas gingivalis partially requires interferon regulatory factor (IRF) 3.
Shaik-Dasthagirisaheb YB; Huang N; Gibson FC
Innate Immun; 2014 Apr; 20(3):312-9. PubMed ID: 23803413
[TBL] [Abstract][Full Text] [Related]
15. Activation of the porcine alveolar macrophages via toll-like receptor 4/NF-κB mediated pathway provides a mechanism of resistin leading to inflammation.
Li B; Fang J; Zuo Z; Yin S; He T; Yang M; Deng J; Shen L; Ma X; Yu S; Wang Y; Ren Z; Cui H
Cytokine; 2018 Oct; 110():357-366. PubMed ID: 29655569
[TBL] [Abstract][Full Text] [Related]
16. Regulation of lipopolysaccharide-induced translation of tumor necrosis factor-alpha by the toll-like receptor 4 adaptor protein TRAM.
Wang L; Trebicka E; Fu Y; Waggoner L; Akira S; Fitzgerald KA; Kagan JC; Cherayil BJ
J Innate Immun; 2011; 3(5):437-46. PubMed ID: 21494017
[TBL] [Abstract][Full Text] [Related]
17. Human Binge Alcohol Intake Inhibits TLR4-MyD88 and TLR4-TRIF Responses but Not the TLR3-TRIF Pathway: HspA1A and PP1 Play Selective Regulatory Roles.
Muralidharan S; Lim A; Catalano D; Mandrekar P
J Immunol; 2018 Apr; 200(7):2291-2303. PubMed ID: 29445009
[TBL] [Abstract][Full Text] [Related]
18. Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-kappaB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signaling.
Sacre SM; Lundberg AM; Andreakos E; Taylor C; Feldmann M; Foxwell BM
J Immunol; 2007 Feb; 178(4):2148-54. PubMed ID: 17277119
[TBL] [Abstract][Full Text] [Related]
19. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway.
Harari OA; Alcaide P; Ahl D; Luscinskas FW; Liao JK
Circ Res; 2006 May; 98(9):1134-40. PubMed ID: 16574902
[TBL] [Abstract][Full Text] [Related]
20. SARM regulates CCL5 production in macrophages by promoting the recruitment of transcription factors and RNA polymerase II to the Ccl5 promoter.
Gürtler C; Carty M; Kearney J; Schattgen SA; Ding A; Fitzgerald KA; Bowie AG
J Immunol; 2014 May; 192(10):4821-32. PubMed ID: 24711619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
